ZM heads into its August 25 earnings release with options positioning at its most defensive reading in months, even as the stock has rallied sharply and short sellers have been quietly retreating.
The clearest pre-earnings signal is in the options market. The put/call ratio hit 0.56 on Friday — more than two standard deviations above its 20-day average of 0.50, the highest z-score reading in the recent period. That's a notable shift: through most of August, options traders were positioned closer to neutral, but the final session before the print saw a meaningful tilt toward downside protection. The move matters more given the stock's context — ZM has climbed nearly 20% over the past month to $107.43, and some of that hedging may reflect profit protection rather than outright bearishness. Borrow conditions offer no amplifying signal in either direction: availability is extraordinarily loose at roughly 7,000% of short interest, and cost to borrow is minimal at 0.37%. Short sellers hold only about 2.7% of the free float, down 4% from a month ago, and there is no sign of squeeze dynamics building.
The analyst community is broadly constructive but not uniformly bullish. Most price targets cluster in the $115–$133 range, and UBS lifted its target to $115 from $105 just ahead of the print, keeping a Neutral rating — a signal the Street sees the stock as fairly valued rather than underpriced after its recent run. Rosenblatt and Needham maintain Buy ratings at $130, while Morgan Stanley and Wells Fargo hold Equal-Weight stances with targets around $105, implying the stock has already reached their fair value. The bull case centres on Zoom's multi-product platform, the Common Room AI acquisition broadening cross-sell opportunities, and a potential convergence of UCaaS and CCaaS that the market may not have fully priced in. Bears point to intensifying competition from Microsoft, the fading structural tailwind from pandemic-era adoption, and a price-to-sales ratio that leaves little room for execution missteps.
One ownership detail is worth noting. Founder and CEO Eric Yuan sold approximately $2 million in stock between August 4–6 at prices around $99–$102 — well below the current $107.43 close. The sales appear routine in size and carry low significance scores, but they add a mild counterweight to the bullish narrative given the stock's subsequent move higher. Norges Bank Investment Management added over 2 million shares in Q2, the most active institutional move among the top holders, suggesting at least one major institution built conviction ahead of this quarter.
The print will test whether Zoom's AI product narrative — and specifically what the Common Room acquisition has done for pipeline and cross-sell — can justify a valuation that has re-rated sharply higher even as forward earnings momentum, at the 29th percentile on a 30-day basis, remains soft.
See the live data behind this article on ORTEX.
Open ZM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
